(2017. május 1.) „In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir”. Antimicrobial Agents and Chemotherapy61 (5), e02558–16. o. DOI:10.1128/AAC.02558-16. PMID 28193664.
(2017. május 1.) „In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir”. Antimicrobial Agents and Chemotherapy61 (5), e02558–16. o. DOI:10.1128/AAC.02558-16. PMID 28193664.